Clinical Trial Update: Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase III study evaluating DSC127 for diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• DSC127

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Diabetic Foot Ulcers | Phase 3 | Status: TERMINATED